Dimitry Ofengeim

Harvard Medical School, Boston, MA, United States 
"Dimitry Ofengeim"
Mean distance: 15.84 (cluster 16)


Sign in to add mentor
R. Suzanne Zukin grad student 2004-2010 Yeshiva University
 (Early cellular and molecular mechanisms underlying ischemia-induced neuronal death.)
Junying Yuan post-doc Harvard Medical School
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kim H, Urquhart R, Pontarelli F, et al. (2023) Protocol for establishing a global ischemia model using a 4-vessel occlusion in rats. Star Protocols. 4: 102630
Vitale I, Pietrocola F, Guilbaud E, et al. (2023) Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death and Differentiation
Mifflin L, Ofengeim D, Yuan J. (2020) Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nature Reviews. Drug Discovery
Degterev A, Ofengeim D, Yuan J. (2019) Targeting RIPK1 for the treatment of human diseases. Proceedings of the National Academy of Sciences of the United States of America
Yuan J, Amin P, Ofengeim D. (2018) Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nature Reviews. Neuroscience
Su Z, Dziedzic SA, Hu D, et al. (2018) ABIN-1 heterozygosity sensitizes to innate immune response in both RIPK1-dependent and RIPK1-independent manner. Cell Death and Differentiation
Xu D, Jin T, Zhu H, et al. (2018) TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging. Cell
Amin P, Florez M, Najafov A, et al. (2018) Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis. Proceedings of the National Academy of Sciences of the United States of America
Chen H, Kankel MW, Su SC, et al. (2018) Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD. Cell Death and Differentiation
Ouchida AT, Li Y, Geng J, et al. (2018) Synergistic effect of a novel autophagy inhibitor and Quizartinib enhances cancer cell death. Cell Death & Disease. 9: 138
See more...